TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05720117: A Study of PYX-201 in Advanced Solid Tumors

Sponsor: Pyxis Oncology, Inc · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 330 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$911,064

Rescue Site Savings

+$596,904

Unlock Full NCT05720117 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05720117 Rescue Dossier →